Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual Antiplatelet Therapy for Shock Patients With Acute Myocardial Infarction
2018-002161-19Phase 4Completed
- Sponsor
- Faculty Hospital Kralovske Vinohrady
- Start
- Jun 2018
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cangrelor and ticagrelor in cardiogenic shock and myocardial infarction (MI) (2 arms), sponsored by Faculty Hospital Kralovske Vinohrady. Primary endpoint: ADP-induced platelet aggregation. Started Jun 2018; status: completed.
02
Drugs
cangrelorticagrelor
03
Conditions
cardiogenic shockmyocardial infarction (MI)
Beyond the preview
Go deeper on 2018-002161-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002161-19.